Natera (NTRA) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

NTRA Natera

Watchlist

155.590
-1.020-0.65%

Close Feb 28 16:00 ET

157.000
+1.410+0.91%

Post 20:01 ET

21.03BMarket Cap-101.69P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

A Quick Look at Today's Ratings for Natera(NTRA.US), With a Forecast Between $188 to $211
Moomoo NewsMar 1 08:00 ET · Ratings
Insider Sale: Director at $NTRA Sells 744 Shares
Quiver QuantitativeFeb 28 21:15 ET
Natera Is Maintained at Outperform by Baird
Dow JonesFeb 28 09:29 ET · Ratings
Natera Analyst Ratings
BenzingaFeb 28 09:15 ET · Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Natera (NTRA), Argenx Se (ARGX) and DENTSPLY SIRONA (XRAY)
TipRanksFeb 28 08:50 ET · Ratings
Natera Price Target Raised to $188 From $183 at Baird
TipRanksFeb 28 08:08 ET

Comments

Ramzi1990

Feb 27 16:02

$Natera (NTRA.US)$ good earnings and good guidance 👍

Teddy123

Feb 25 05:08

Natera Announces Medicare Coverage of Signatera™ for Surveillance in Lung Cancer

$Natera (NTRA.US)$
Natera Scores Critical Medicare Coverage Win for Lung Cancer Test - What This Means for Patients and Investors

Teddy123

Feb 10 06:16

NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma

$Natera (NTRA.US)$
Major Clinical Guidelines Update: Natera's Cancer Test Shows 20x Better Risk Detection

In One Chart

Nov 15, 2024 04:22

Columns Top Institutions Continue to Hold Strong Tech Positions in Q3 13F Filings

The recent release of 13F reports from institutional investors has shed light on the shifting sands of Wall Street's investment landscape. These mandatory filings, required by the U.S. Securities and Exchange Commission (SEC) for institutions managing over $100 million in equity assets, provide a window into the portfolio adjustments of the financial world's heavyweights, including the likes of Berkshire Hathaway, Baillie G...

Warren Buffett boosted stake: Can OXY's Q3 earnings pump its price?

Brianjh

Oct 17, 2024 09:21

Druckenmiller Stock Portfolio

Stanley Druckenmiller says he's ‘licking my wounds’ from selling Nvidia too soon
-Billionaire investor Stanley Druckenmiller told Bloomberg on Wednesday that selling all his Nvidia stock this year was a “big mistake.”
-Nvidia was Druckenmiller's top holding a year ago, but he sold it after the stock tripled in 2023.
-The shares are up another 174% this year, and Druckenmiller has missed much of the continuing rally.
Stanley Druckenmiller is an American billionair...

Teach and Learn Together here!

NTRA Natera

Trade Overview

Capital Trend

News

Comments

Trending Stocks